Oleander Cardiac Compound
A purified oleander glycoside compound supplied to cardiology research under strict licensing.
Product Overview
Oleander Cardiac Compound is a purified oleander glycoside supplied to cardiology research under strict licensing. Restricted grade, Controlled hazard, Tier-3 clearance, made to order.
Composition & Refinement
Cardiac glycosides — oleandrin and related compounds — are extracted from Sector-7's Nerium stock and purified to a certified concentration for research dosing. Each made-to-order lot is characterized by mass spec, released with a certificate, and supplied at the minimum viable quantity in tamper-evident packaging.
Applications & Clientele
Cardiology and pharmacology programs use it to study glycoside effects on cardiac contractility and rhythm, where the compound's narrow therapeutic index is itself the object of study. Sale is licence-gated, ledger-logged, and tied to a named investigator; the same molecule is a potent cardiotoxin, so disposal returns are mandatory.
Handling & Safety
Oleander Cardiac Compound is a Controlled-hazard toxin. It is handled only under the facility's Toxin Handling SOP by named, cleared custodians, supplied at the minimum viable quantity in tamper-evident packaging, and tracked in the controlled-substance ledger from dispatch to the client's mandatory disposal return.
Provenance & Licensing
Produced under full containment at Sector-7 and gated to Tier-3 clearance. Distribution is entered in the controlled ledger against a named, licensed institution and responsible custodian; re-propagation or resale rights are withheld and, for toxin lines, a disposal return is mandatory.
Catalogue revenue flows to the Commercial Directorate and underwrites the facility's restricted research programs. See Finance →